Projects per year
Fingerprint
Dive into the research topics where Ralph A Defronzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
Project: Research project
-
SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION
Project: Research project
-
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
Project: Research project
-
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
Abboud, H. E., Blangero, J. C., Duggirala, R., Lehman, D. M., Blangero, J. C., Defronzo, R. A., Duggirala, R., Lehman, D. M., Duggirala, R. & Blangero, J. C.
Project: Research project
-
Womb to Tomb: Developmental Programming and Aging Interactions in Primates
Cox, L., Clarke, G. D., Lanford, R. E., Fox, P. T., Cox, L., Defronzo, R. A. & Clarke, G. D.
Project: Research project
Research output
-
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
Lavynenko, O., Abdul-Ghani, M., Alatrach, M., Puckett, C., Adams, J., Abdelgani, S., Alkhouri, N., Triplitt, C., Clarke, G. D., Vasquez, J. A., Li, J., Cersosimo, E., Gastaldelli, A. & DeFronzo, R. A., May 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 899-907 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose
Alatrach, M., Agyin, C., Solis-Herrera, C., Lavryneko, O., Adams, J., Gastaldelli, A., Triplitt, C., Defronzo, R. A. & Cersosimo, E., Jun 2 2022, In: Diabetes care. 45, 6, p. 1372-1380 9 p.Research output: Contribution to journal › Article › peer-review
-
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Dagogo-Jack, S., de Boer, I. H., DeFronzo, R. A., Eckel, R. H., Einhorn, D., Fonseca, V. A., Green, J. B., Grunberger, G., Guerin, C., Inzucchi, S. E. & 11 others, , Feb 2022, In: Journal of Diabetes and Its Complications. 36, 2, 108101.Research output: Contribution to journal › Review article › peer-review
Open Access -
Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance
Spence, J. D., Viscoli, C., Kernan, W. N., Young, L. H., Furie, K., DeFronzo, R., Abdul-Ghani, M., Dandona, P. & Inzucchi, S. E., Jun 2022, In: Diabetes, Obesity and Metabolism. 24, 6, p. 1150-1158 9 p.Research output: Contribution to journal › Article › peer-review
-
Insulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A. & DeFronzo, R. A., Apr 2022, In: Metabolism: Clinical and Experimental. 129, 155142.Research output: Contribution to journal › Review article › peer-review